SCHEMBL20149429

SCHEMBL20149429

c1ccc2c(c1)cc(-n1c3ccccc3c3ccc(-c4ccc5c6ccccc6n(-c6cc7ccccc7c7ccccc67)c5c4)cc31)c1ccccc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
TDP1 Q9NUW8 1/20 0.39
HPRT1 P00492 3/20 0.38
KDM4E B2RXH2 1/20 0.37
ATM Q13315 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
ALDH1A1 P00352 2/20 0.37
TRPM4 Q8TD43 1/20 0.36
HIF1A Q16665 1/20 0.35
CYP1B1 Q16678 1/20 0.35
HSD17B10 Q99714 1/20 0.35
RXRA P19793 1/20 0.35
RXRB P28702 1/20 0.35
ERBB2 P04626 1/20 0.33
FYN P06241 1/20 0.33
MAOA P21397 1/20 0.33
ACHE P22303 1/20 0.33
AHR P35869 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20149473 0.95 CYP1A2 (0.42) CYP1A2CYP2C9CYP2C19TDP1HPRT1
SCHEMBL15480218 0.93 L3MBTL1 (0.51) CYP1A2CYP2C9CYP2C19TDP1HPRT1
SCHEMBL19132147 0.90 L3MBTL1 (0.41) CYP1A2CYP2C9CYP2C19TDP1HPRT1
SCHEMBL22505117 0.90 L3MBTL1 (0.45) CYP1A2CYP2C9CYP2C19TDP1KDM4E
SCHEMBL15964341 0.90 CYP1A2 (0.41) CYP1A2CYP2C9CYP2C19TDP1HPRT1
SCHEMBL18086214 0.89 CYP1A2 (0.49) CYP1A2CYP2C9CYP2C19TDP1HPRT1
SCHEMBL29827886 0.89 CYP1A2 (0.49) CYP1A2CYP2C9CYP2C19TDP1HPRT1
SCHEMBL10130250 0.89 CYP1A2 (0.45) CYP1A2CYP2C9CYP2C19TDP1HPRT1
SCHEMBL23118683 0.89 CYP1A2 (0.38) CYP1A2CYP2C9CYP2C19TDP1KDM4E
SCHEMBL15480134 0.89 L3MBTL1 (0.47) CYP1A2CYP2C9CYP2C19TDP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230139757-A1 ORGANIC ELECTROLUMINESCENT DEVICE NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2023-05-04 US disclosed
US-20230139757-A1 ORGANIC ELECTROLUMINESCENT DEVICE NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2023-05-04 US disclosed
US-20230023388-A1 ORGANIC ELECTROLUMINESCENT ELEMENT NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2023-01-26 US disclosed
US-20220173326-A1 MELT MIXTURE FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2022-06-02 US disclosed
US-20180138420-A1 ORGANIC ELECTROLUMINESCENT ELEMENT NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2018-05-17 US disclosed
US-20180138420-A1 ORGANIC ELECTROLUMINESCENT ELEMENT NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180138420-A1 ORGANIC ELECTROLUMINESCENT ELEMENT EML4, LAGE3, KCNN4 CYP1A2 613/4885CYP2C9 521/4885CYP2C19 456/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.